An androgen receptor coactivator regulated in prostate
An androgen receptor coactivator regulated in prostate
批准号:
8300227
负责人:
Susan K. Logan
金额:
$34.12万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2015-03-31
关键词:
AR geneAblationAccountingAffectAndrogen ReceptorAndrogensAntiandrogen TherapyApoptosisBindingBiologyCancer BiologyCell Cycle CheckpointCell Cycle ProgressionCell Differentiation processCell ProliferationCellsComplexDNA-Directed RNA PolymeraseDevelopmentDiagnostic Neoplasm StagingDoseEnhancersEpithelial CellsGene AmplificationGene Expression RegulationGene MutationGene TargetingGenesGenetic ProgrammingGenetic TranscriptionGenomicsGoalsGrantGrowthHealthHormonesHumanInterventionInvestigationLNCaPLesionMaintenanceMalignant - descriptorMalignant neoplasm of prostateMediatingMessenger RNAMetabolismMinorityMultiprotein ComplexesMusMutagenesisMutationNuclear ExtractOutcomePC3 cell linePhysiologicalPlayProstateProstate Cancer therapyProstatic Intraepithelial NeoplasiasProteinsReceptor GeneReceptor SignalingRefractory DiseaseRegulationRegulator GenesReportingResistanceRoleSamplingSedimentation processTestingTranscriptional ActivationTranscriptional RegulationUndifferentiatedbasecell growthcell typecofactorhormone therapyin vivolink proteinmembernovelprefoldinprogramspromoterprotein functionreceptortherapy resistanttumor progressionyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The focus of this proposal is on Androgen Receptor Trapped clone-27 (ART-27) and Unconventional prefoldin RBP5 Interactor (URI), two proteins that interact with one another and have a major impact on transcriptional regulation through the Androgen Receptor (AR). During prostate development in humans, ART-27 is expressed in differentiated luminal epithelial cells but is not detected in undifferentiated epithelial cell precursors, suggesting a role for ART-27 in AR-mediated growth suppression and differentiation. Consistent with a growth suppressive function, ART-27 expression levels are decreased in human prostate cancer and regulated expression of ART-27 in the androgen sensitive LNCaP prostate cancer cell line inhibits androgen- mediated cellular proliferation. Moreover, a somatic alteration in AR (AR P340L) derived from a prostate cancer shows diminished capacity to enhance ART-27 mediated AR-transcriptional activation. Further, a recent report and our two-hybrid results indicate that ART-27 associates with Unconventional prefoldin RBP5 Interactor (URI) forming complexes with RPB5, a subunit of RNA polymerase, to control transcription programs. URI is implicated in maintenance of genomic integrity and a recent profiling of staged cancer samples indicates that URI is one a group of genes up-regulated in Prostatic Intraepithelial Neoplasia (PIN), a proliferative lesion thought to be a precursor to prostate cancer. Based on these findings, we hypothesize that ART-27 is a cell type specific and developmentally regulated protein that links AR to the URI transcriptional regulatory complex and affects AR target genes important in prostate growth regulation. To test this hypothesis we propose to: 1) Identify ART-27-dependent AR- target genes and the impact of ART-27 and URI on cell cycle progression 2) Determine if ART-27 and URI function independently to direct AR-mediated gene transcription and 3) Elucidate the role of ART-27 in prostate epithelial cell growth and differentiation in vivo. The over-riding hypothesis of this proposal is that AR cofactors modulate specific programs of gene transcription that aid and abet tumor progression. ART-27 and URI are novel members of a transcription complex that clearly play an important role in AR signaling, yet very little is known about the function of these proteins in the prostate. The long-term goal is to understand how AR directs cell metabolism and differentiation in some cellular contexts and proliferation in others. PUBLIC HEALTH RELEVANCE: While prostate cancers are initially treatable by anti-hormone therapy, they inevitably become resistant to therapy resulting in few treatment options. The focus of this grant is to understand the biology leading to anti- hormone resistant prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Suppression of Prostate Cancer
-
批准号:10512253
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2022
-
负责人:Susan K. Logan
-
依托单位:
Suppression of Prostate Cancer
-
批准号:10684749
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2022
-
负责人:Susan K. Logan
-
依托单位:
An androgen receptor coactivator regulated in prostate
-
批准号:8761290
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2013
-
负责人:Susan K. Logan
-
依托单位:
An androgen receptor coactivator regulated in prostate
-
批准号:7893772
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2008
-
负责人:Susan K. Logan
-
依托单位:
Transcription repression in prostate cancer
-
批准号:9449390
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2008
-
负责人:Susan K. Logan
-
依托单位:
An androgen receptor coactivator regulated in prostate
-
批准号:8102125
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2008
-
负责人:Susan K. Logan
-
依托单位:
An androgen receptor coactivator regulated in prostate
-
批准号:7683054
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2008
-
负责人:Susan K. Logan
-
依托单位:
An androgen receptor coactivator regulated in prostate
-
批准号:7526936
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2008
-
负责人:Susan K. Logan
-
依托单位:
DEVELOPMENTALLY REGULATED CYTOTROPHOBLAST CELL INVASION
-
批准号:3034513
-
项目类别:
-
资助金额:$2.62万
-
财政年份:1991
-
负责人:Susan K. Logan
-
依托单位:
DEVELOPMENTALLY REGULATED CYTOTROPHOBLAST CELL INVASION
-
批准号:3034512
-
项目类别:
-
资助金额:$2.1万
-
财政年份:1991
-
负责人:Susan K. Logan
-
依托单位:
海外基金